Holen Sie sich die Stockscreener-App
37.81
0.75%
0.28
Handel nachbörslich:
37.63
-0.18
-0.48%
Schlusskurs vom Vortag:
$37.53
Offen:
$37.85
24-Stunden-Volumen:
1.65M
Relative Volume:
0.65
Marktkapitalisierung:
$4.47B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$251.00M
KGV:
19.15
EPS:
1.9744
Netto-Cashflow:
$-193.86M
1W Leistung:
+2.22%
1M Leistung:
+13.78%
6M Leistung:
+12.93%
1J Leistung:
+235.79%
1-Tages-Spanne:
$37.48
$38.58
1-Wochen-Bereich:
$36.77
$38.58
52-Wochen-Spanne:
$11.49
$41.00
Indivior Pharmaceuticals Inc Stock (INDV) Company Profile
Firmenname
Indivior Pharmaceuticals Inc
Sektor
Telefon
804-379-1090
Adresse
10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD
Compare INDV vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDV
Indivior Pharmaceuticals Inc
|
37.81 | 4.44B | 1.29B | 251.00M | -193.86M | 1.9744 |
TAK
Takeda Pharmaceutical Co Adr
|
15.87 | 51.34B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.24 | 41.15B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.61 | 39.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
80.23 | 34.09B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
578.43 | 24.13B | 3.17B | 1.29B | 1.01B | 27.09 |
Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-22 | Fortgesetzt | Jefferies | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-07-23 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-03 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-13 | Eingeleitet | Northland Capital | Outperform |
Alle ansehen
Indivior Pharmaceuticals Inc Aktie (INDV) Neueste Nachrichten
Free cash flow of Indivior Pharmaceuticals, Inc. – GETTEX:E7P - TradingView
Equity in earnings of Indivior Pharmaceuticals, Inc. – GETTEX:E7P - TradingView
Indivior Pharmaceuticals, Inc. Revenue Breakdown – GETTEX:E7P - TradingView
Bears are losing control over Indivior Pharmaceuticals Inc. (INDV), here's why it's a 'buy' now - MSN
Does Indivior Pharmaceuticals Inc. (INDV) have the potential to rally 32.48% as Wall Street analysts expect? - MSN
INDV Stock Chart | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill
Does Indivior Pharmaceuticals Inc. (INDV) Have the Potential to Rally 32.48% as Wall Street Analysts Expect? - Yahoo Finance
Indivior launches $175M accelerated share buyback - MSN
Indivior (INDV) Shows Benefits of Sublocade for Opioid Use Disor - GuruFocus
Debt to assets ratio of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Price to cash flow ratio of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Preferred dividends of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Revenue Breakdown – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Income Statement – MUN:E7P - TradingView
Book value per share of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Earnings and Revenue – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Balance Sheet – MUN:E7P - TradingView
New Studies Show Adherence to Monthly Injectable - GlobeNewswire
The Bull Case For Indivior Pharmaceuticals (INDV) Could Change Following Upgraded Outlook And $175M BuybackLearn Why - Yahoo Finance
Assessing Indivior Pharmaceuticals (INDV) Valuation After Strong Long Term Share Price Momentum - Sahm
Indivior Pharmaceuticals Inc. (INDV) upgraded to strong buy: Here's what you should know - MSN
Indivior Pharmaceuticals Inc. (INDV) is a great choice for 'trend' investors, here's why - MSN
BMRN Stock Down on Mixed Results From Rare Disease Therapy Study - TradingView
INDV News | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill
Indivior Pharmaceuticals Inc. (INDV) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Indivior Pharmaceuticals Inc. (INDV) Q1 earnings and revenues beat estimates - MSN
Indivior Pharmaceuticals, Inc.Common Stock (Nasdaq:INDV) Stock Quote - The Chronicle-Journal
Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership - The Globe and Mail
Suboxone Tooth Decay Lawsuit Settlement May 2026 Update - Lawsuit Information Center
Indivior PLC stock (US45580R1068): earnings momentum and rising EPS estimates attract attention - AD HOC NEWS
Indivior (NASDAQ: INDV) ends CSO role and reports 2026 shareholder vote outcomes - Stock Titan
Madison Avenue entities (INDV) disclose 4.32M-share, ~3.5% stake - Stock Titan
Bears are Losing Control Over Indivior Pharmaceuticals Inc. (INDV), Here's Why It's a 'Buy' Now - Yahoo Finance
Indivior to Participate in Upcoming Investor Conferences - GlobeNewswire
Naloxone Market to See Booming Growth 2026-2033 | EMERGENT, Indivior PLC, Akorn, Inc - openPR.com
Indivior’s CEO lines up June investor meetings in New York and Miami - Stock Titan
Fuller & Thaler Asset Mgmt (NASDAQ: INDV) holds 4.53M shares, 3.72% - Stock Titan
Number of shareholders of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView
Why One Fund Made a $23 Million Bet on This Addiction-Treatment Stock Amid a Staggering Rally - AOL.com
Net income before discontinued operations of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView
Equity in earnings of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView
Working capital per share of Indivior Pharmaceuticals, Inc. – TRADEGATE:E7P - TradingView
Indivior Pharmaceuticals, Inc. Balance Sheet – TRADEGATE:E7P - TradingView
Indivior Pharmaceuticals, Inc. Income Statement – TRADEGATE:E7P - TradingView
BDTX Shares Gain 11% in a Week: Here's What You Should Know - TradingView
State of New Jersey Common Pension Fund D Raises Stock Position in Indivior PLC $INDV - MarketBeat
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Its Strong Recent Share Price Run - Yahoo Finance
Vanguard Group Inc. Acquires 2,008,078 Shares of Indivior PLC $INDV - MarketBeat
Finanzdaten der Indivior Pharmaceuticals Inc-Aktie (INDV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Indivior Pharmaceuticals Inc-Aktie (INDV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kingsley Stuart A | Director |
Mar 06 '26 |
Buy |
31.86 |
940 |
29,953 |
5,582 |
| Ryan Barbara | Director |
Mar 09 '26 |
Buy |
32.56 |
31 |
1,009 |
5,716 |
| Ryan Barbara | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
1,963 |
| Humphreys Keith | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
5,802 |
| NINIVAGGI DANIEL A | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
16,923 |
| Stejbach Mark | Director |
Jan 05 '26 |
Buy |
35.39 |
775 |
27,429 |
16,847 |
| Wheadon David E. | Director |
Jan 05 '26 |
Buy |
35.39 |
1,771 |
62,680 |
14,395 |
5.02%
5.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):